Pro-Pharmaceuticals, Inc. To Present A Corporate Update At Rodman & Renshaw Healthcare Conference; “Advancing Drugs Through Glycoscience’” Presentation To Be Webcast

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate therapeutic compounds, today announced that David Platt, Ph.D., Chief Executive Officer of Pro-Pharmaceuticals, Inc., is scheduled to present a corporate overview and update on Monday, November 6 at 2:50 p.m. (Eastern Time) at the Rodman & Renshaw 8th Annual Healthcare Conference to be held at the Palace Hotel in New York City. The presentation is scheduled to be webcast live and can be accessed at the Company’s website: http://www.pro-pharmaceuticals.com, Investor Relations “Calendar of Events” section, or by accessing: http://wsw.com/webcast/rrshq10/prw.

MORE ON THIS TOPIC